Page last updated: 2024-11-06

prolinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

prolinol: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

prolinol : An amino alcohol formed by reduction of the amino acid proline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID640091
CHEMBL ID1916080
SCHEMBL ID115932
MeSH IDM0056048

Synonyms (65)

Synonym
l-(+)-prolinol
(s)-pyrrolidin-2-ylmethanol
(s)-(+)-prolinol
(2s)-pyrrolidin-2-ylmethanol
prolinol
(s)-(+)-2-pyrrolidinemethanol, 97%
l-prolinol
23356-96-9
(s)-(+)-2-pyrrolidinemethanol
(s)-(+)-2-(hydroxymethyl)pyrrolidine
[(2s)-pyrrolidin-2-yl]methanol
AKOS005259889
EN300-70033
A816682
(s)-2-hydroxymethylpyrrolidine
l5gd8ldg49 ,
prolinol, (s)-
CHEMBL1916080 ,
bdbm50357222
(s)-2pyrrolidinemethanol
(2s)-pyrrolidine-2-methanol
(s)-(+)-2-pyrrolidine-methanol
(2s)-2-(hydroxymethyl)pyrrolidine
(s)-prolinol
(s)-(-)-2-(hydroxymethyl)-pyrrolidine
HVVNJUAVDAZWCB-YFKPBYRVSA-N
(s)-pyrrolidin-2-yl-methanol
(l)-prolinol
pro-ol
2(s)-hydroxymethylpyrrolidine
(s)-2-pyrrolidinemethanol
(2s)-2-hydroxymethyl-pyrrolidine
(s)-2-(hydroxymethyl)pyrrolidin
(s)-(+)-2-pyrrolidine methanol
(s)-(-)-pyrrolidin-2-yl-methanol
2-(s)-pyrrolidinemethanol
(s)-1-pyrrolidin-2-ylmethanol
2-(s)-(hydroxymethyl)pyrrolidine
2-hydroxymethyl-(s)-pyrrolidine
(s)-2-pyrrolidine methanol
(2s)-2-pyrrolidinylmethanol
(2s)-2-pyrrolidinemethanol
(s)-2-(hydroxymethyl)pyrrolidine
(2s)-2-hydroxymethylpyrrolidine
(s)-1-pyrrolidin-2-yl-methanol
(s)-2-hydroxymethyl-pyrrolidine
SCHEMBL115932
AM82208
W-107405
2-pyrrolidinemethanol, (2s)-
PS-9388
mfcd00005255
(s)-(+)- prolinol
M03445
AC-8565
CS-D1460
F0001-0809
h-pro-ol
(+)-2-pyrrolidinemethanol
2-pyrrolidinemethanol hydrochloride
2-pyrrolidinemethanol, (s)-
l-2-(hydroxymethyl)pyrrolidine
(s)-(+)-prolinol, 95%
(s)-(+)-prolinol, 95per cent
Z1123715411

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The two compounds were characterised by an inverted U-shaped dose-response curve, and their effects were blocked by the co-administration of the antagonist MCL-117, which alone had no effect."( Behavioural and pharmacological profiles of zebrafish administrated pyrrolidinyl benzodioxanes and prolinol aryl ethers with high affinity for heteromeric nicotinic acetylcholine receptors.
Appiani, R; Bavo, F; Bolchi, C; Braida, D; Gotti, C; Moretti, M; Pallavicini, M; Ponzoni, L; Sala, M; Viani, P, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
monoatomic ion transportProton-coupled amino acid transporter 1Homo sapiens (human)
amino acid transportProton-coupled amino acid transporter 1Homo sapiens (human)
taurine transmembrane transportProton-coupled amino acid transporter 1Homo sapiens (human)
proline transportProton-coupled amino acid transporter 1Homo sapiens (human)
alanine transportProton-coupled amino acid transporter 1Homo sapiens (human)
amino acid import across plasma membraneProton-coupled amino acid transporter 1Homo sapiens (human)
glycine transportProton-coupled amino acid transporter 1Homo sapiens (human)
proline transmembrane transportProton-coupled amino acid transporter 1Homo sapiens (human)
proton transmembrane transportProton-coupled amino acid transporter 1Homo sapiens (human)
L-alanine transportProton-coupled amino acid transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
amino acid:proton symporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
proline:proton symporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
taurine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
protein bindingProton-coupled amino acid transporter 1Homo sapiens (human)
amino acid transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
alanine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
L-alanine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
L-proline transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
glycine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
lysosomal membraneProton-coupled amino acid transporter 1Homo sapiens (human)
endoplasmic reticulumProton-coupled amino acid transporter 1Homo sapiens (human)
plasma membraneProton-coupled amino acid transporter 1Homo sapiens (human)
apical plasma membraneProton-coupled amino acid transporter 1Homo sapiens (human)
vacuolar membraneProton-coupled amino acid transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID630741Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.13)18.7374
1990's2 (4.26)18.2507
2000's20 (42.55)29.6817
2010's23 (48.94)24.3611
2020's1 (2.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.26%)6.00%
Case Studies1 (2.13%)4.05%
Observational0 (0.00%)0.25%
Other44 (93.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]